UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $700
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice TargetHot
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $627 to $700.
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $627 to $700.